Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating vascular eye disorders with actrii antagonists

Methods for treating vascular eye disorders with actrii antagonists

US Patent 10550170 · Granted Feb 4, 2020

Estimated economic value: $73,913,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating vascular eye disorders with ActRII antagonists2022
Methods for treating vascular eye disorders with ActRII antagonists2022
Activin-ActRII antagonists and uses for treating anemia2022
Methods and compositions for treating ulcers2022
Methods for treating myelodysplastic syndromes and sideroblastic anemias2020
Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB 2019
Methods for treating myelodysplastic syndromes and sideroblastic anemias2019
Antagonists of activin-ActRIIa and uses for increasing red blood cell levels2018
Follistatin fusion proteins and uses thereof2018
Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide2017
Activin-actriia antagonists for treating a follicle-stimulating horomone-secreti2016
Antagonists of activin-actriia and uses for increasing red blood cell levels2014